UNSPSC 51333006: Molindone hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C16H24N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1DWS68PNE6, chemically known as 4h-indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-, monohydrochloride but more generally known as molindone hydrochloride, which bears US NIH Compound Identifier 27421. European Medicines Agency schedules Molindone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14587MIG.

UNSPSC 51333006 Molindone hydrochloride is a Commodity code that nominally covers a specific antipsychotic pharmaceutical, but recent state and local procurement activity tagged to this code shows little alignment with the code's stated scope. The three most recent opportunities — a Seminole County naloxone and drug deactivation systems procurement, a Texas HHS Therapeutic Pharmacy Initiative information request, and a Minnesota Multistate Cooperative Purchasing Alliance generic pharmaceuticals contract — do not specifically solicit molindone hydrochloride or pharmaceutical manufacturing at the commodity level. Instead, the opportunities span pharmacy benefit program management, naloxone distribution for overdose response, and broad-based generic pharmaceutical supply contracts covering multiple drug categories through authorized wholesalers. This mismatch suggests either misclassification in the posting process or that molindone hydrochloride procurement occurs under different codes or is not actively solicited through formal state and local channels at present.

The issuing bodies reflect the diversity typical of health-related procurement: county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and cooperative purchasing consortiums serving multi-state and local government participation (MMCAP, administered by Minnesota Department of Administration). Recent activity centers in Florida, Texas, and Minnesota, with participation from Oregon through MMCAP. No concrete recent opportunity for molindone hydrochloride specifically appears in the available records. Business development professionals evaluating this code should verify whether it remains active for state and local procurement or whether related pharmaceutical solicitations route through higher-level family or class codes covering generic drugs and pharmacy benefit management instead.